March 7 (Reuters) - PuraPharm Corp Ltd 1498.HK :
* EXPECTED THAT GROUP'S REVENUE FOR YEAR ENDED 31 DECEMBER
2018
WILL RECORD AN INCREASE OF MORE THAN 20%
* PROFIT FOR YEAR ENDED 31 DECEMBER 2018 WILL ALSO RECORD A
SUBSTANTIAL INCREASE
* EXPECTED TO RECORD A NET PROFIT OF MORE THAN HK$15 MILLION
FOR
YEAR ENDED 31 DECEMBER 2018
* EXPECTED INCREASE IN REVENUE DUE TO INCREASE IN SALES OF
GROUP'S
CHINA CONCENTRATED CHINESE MEDICINE GRANULES SEGMENT
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7sbrPR
Further company coverage: 1498.HK
((Reuters.Briefs@thomsonreuters.com;))